Condition: Acute Lymphoblastic Leukemia ALL · Sponsor: Institute of Hematology & Blood Diseases Hospital, China
To observe the efficacy and side effects of autologous hematopoietic stem cell transplantation combined with CD19-CART for adult acute lymphoblastic leukemia, and to evaluate the safety and efficacy of this regimen in the treatment of acute lymphoblastic leukemia.
This description comes directly from the study's public registry record.
erlie EL Jiang · +86-15122538106 · jiangerlie@ihcams.ac.cn
Always discuss trial participation with your own doctor first.
| NO.288 Nanjing Road，Heping District，Tianjin, Tianjin, | Tianjin, Tianjin Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06608342